232 related articles for article (PubMed ID: 32274709)
1. An Overview of the Structure, Mechanism and Specificity of Human Heparanase.
Wu L; Davies GJ
Adv Exp Med Biol; 2020; 1221():139-167. PubMed ID: 32274709
[TBL] [Abstract][Full Text] [Related]
2. Structural characterization of human heparanase reveals insights into substrate recognition.
Wu L; Viola CM; Brzozowski AM; Davies GJ
Nat Struct Mol Biol; 2015 Dec; 22(12):1016-22. PubMed ID: 26575439
[TBL] [Abstract][Full Text] [Related]
3. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
4. Heparanase: Historical Aspects and Future Perspectives.
Khanna M; Parish CR
Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
[TBL] [Abstract][Full Text] [Related]
5. Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-D-glucuronidase (heparanase).
Gandhi NS; Freeman C; Parish CR; Mancera RL
Glycobiology; 2012 Jan; 22(1):35-55. PubMed ID: 21746763
[TBL] [Abstract][Full Text] [Related]
6. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
[TBL] [Abstract][Full Text] [Related]
7. Heparanase Inhibitors in Cancer Progression: Recent Advances.
Kaur R; Deb PK; Diwan V; Saini B
Curr Pharm Des; 2021; 27(1):43-68. PubMed ID: 33185156
[TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycans affect heparanase location in CHO cell lines.
Piva MB; Suarez ER; Melo CM; Cavalheiro RP; Nader HB; Pinhal MA
Glycobiology; 2015 Sep; 25(9):976-83. PubMed ID: 26033936
[TBL] [Abstract][Full Text] [Related]
9. Non-reducing end labeling of heparan sulfate via click chemistry and a high throughput ELISA assay for heparanase.
Wu ZL; Huang X; Ethen CM; Tatge T; Pasek M; Zaia J
Glycobiology; 2017 Jun; 27(6):518-524. PubMed ID: 28025251
[TBL] [Abstract][Full Text] [Related]
10. Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis.
Roy M; Marchetti D
J Cell Biochem; 2009 Feb; 106(2):200-9. PubMed ID: 19115257
[TBL] [Abstract][Full Text] [Related]
11. Multi-faceted substrate specificity of heparanase.
Peterson SB; Liu J
Matrix Biol; 2013 Jun; 32(5):223-7. PubMed ID: 23499529
[TBL] [Abstract][Full Text] [Related]
12. Heparanase and autoimmune diabetes.
Simeonovic CJ; Ziolkowski AF; Wu Z; Choong FJ; Freeman C; Parish CR
Front Immunol; 2013 Dec; 4():471. PubMed ID: 24421779
[TBL] [Abstract][Full Text] [Related]
13. Recent data concerning heparanase: focus on fibrosis, inflammation and cancer.
Secchi MF; Masola V; Zaza G; Lupo A; Gambaro G; Onisto M
Biomol Concepts; 2015 Dec; 6(5-6):415-21. PubMed ID: 26552066
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between tumor cells and lymphocytes modulates heparanase expression.
Theodoro TR; Matos LL; Cavalheiro RP; Justo GZ; Nader HB; Pinhal MAS
J Transl Med; 2019 Mar; 17(1):103. PubMed ID: 30922347
[TBL] [Abstract][Full Text] [Related]
15. Chemical toolbox to interrogate Heparanase-1 activity.
Rabinowitz ZM; Somers J; Wang Z; Cui L
Curr Opin Chem Biol; 2024 Mar; 80():102452. PubMed ID: 38555836
[TBL] [Abstract][Full Text] [Related]
16. Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo.
de Boer C; Armstrong Z; Lit VAJ; Barash U; Ruijgrok G; Boyango I; Weitzenberg MM; Schröder SP; Sarris AJC; Meeuwenoord NJ; Bule P; Kayal Y; Ilan N; Codée JDC; Vlodavsky I; Overkleeft HS; Davies GJ; Wu L
Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2203167119. PubMed ID: 35881786
[TBL] [Abstract][Full Text] [Related]
17. 1H NMR spectroscopic studies establish that heparanase is a retaining glycosidase.
Wilson JC; Laloo AE; Singh S; Ferro V
Biochem Biophys Res Commun; 2014 Jan; 443(1):185-8. PubMed ID: 24291708
[TBL] [Abstract][Full Text] [Related]
18. FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells.
Reiland J; Kempf D; Roy M; Denkins Y; Marchetti D
Neoplasia; 2006 Jul; 8(7):596-606. PubMed ID: 16867222
[TBL] [Abstract][Full Text] [Related]
19. Molecular Aspects of Heparanase Interaction with Heparan Sulfate, Heparin and Glycol Split Heparin.
Elli S; Guerrini M
Adv Exp Med Biol; 2020; 1221():169-188. PubMed ID: 32274710
[TBL] [Abstract][Full Text] [Related]
20. Pro-Angiogenic Effects of Latent Heparanase and Thrombin Receptor-Mediated Pathways-Do They Share a Common Ground in Melanoma Cells?
Hoß SG; Grundmann M; Benkel T; Gockel L; Schwarz S; Kostenis E; Schlesinger M; Ilan N; Vlodavsky I; Bendas G
Thromb Haemost; 2018 Oct; 118(10):1803-1814. PubMed ID: 30235481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]